Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trickle Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (831)	9/21/2001 1:55:45 PM
From: tuck	Read Replies (1) \| Respond to of 1784

But first the good news: >>HERCULES, Calif., Sept. 21 /PRNewswire/ -- Bio-Rad Laboratories, Inc. (Amex: BIO.A; BIO.B) announced today that the company intends to resume repurchasing its common stock via market purchase or privately negotiated transactions. This is a continuation of a partially completed ten million dollar ($10,000,000) common share repurchase program, which was authorized in 1998. ``The recent decline in the price of our stock provides the opportunity to improve shareholder value, cover our future obligations under the company's employee stock purchase and option plans, and take advantage of the American Stock Exchange's recent changes in stock repurchase program requirements,'' said David Schwartz, President and Chief Executive Officer.<< snip Cheers, Tuck